|
|
|
|
|
|
by yholio
2705 days ago
|
|
|
> The research team hope that their software could help pharmaceutical companies in the protection of their intellectual property, and to hasten research into organic chemistry. It seems what they are attempting to sell is a IP protection service: let us show you other molecules and synesis routes you should also patent defensively, without actually attempting them in practice. Pretty soon you will have algorithmically defined patents. It's IP anti-science at it's worst. |
|
|
Which to be fair is probably very unlikely given how healthcare costs and whatnot work in America. Can always bump the price up to compensate for expenses.
BUT - this is still a very useful tool for locating possibly cheaper/simpler methods of producing drugs that have expired protections. There is a project out there that is working on a bioreactor kit that allows the safe home production of several common drugs that are not patent protected. There are also projects that could have been life saving but were already not financially viable that could be rescued by this program.
And if someone is fast enough and has the funds to burn, they could patent some of those processes and then do what Tesla did with their patents.
I think this may open up more opportunities in the long run than it closes.